Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Igaz, P; Bosze, S; Toth, S; Falus, A; Hudecz, F
   C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells
   BIOLOGICAL CHEMISTRY
   
   P. Igaz et al., "C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells", BIOL CHEM, 382(4), 2001, pp. 669-676
2. Mizuguchi, H; Mizuno, H; Yasukawa, K; Ishiguro, T; Fukui, K; Imanaka, T; Takagi, M
   Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor
   JOURNAL OF BIOSCIENCE AND BIOENGINEERING
   
   H. Mizuguchi et al., "Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor", J BIOSCI BI, 91(3), 2001, pp. 299-304
3. Bracho, F; Krailo, MD; Shen, V; Bergeron, S; Davenport, V; Liu-Mares, W; Blazar, BR; Panoskaltsis-Mortari, A; van de Ven, C; Secola, R; Ames, MM; Reid, JM; Reaman, GH; Cairo, MS
   A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities
   CLINICAL CANCER RESEARCH
   
   F. Bracho et al., "A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities", CLIN CANC R, 7(1), 2001, pp. 58-67
4. Zietz, B; Hrach, S; Scholmerich, J; Straub, RH
   Differential age-related changes of hypothalamus pituitary adrenal axis hormones in healthy women and men - Role of interleukin 6
   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
   
   B. Zietz et al., "Differential age-related changes of hypothalamus pituitary adrenal axis hormones in healthy women and men - Role of interleukin 6", EXP CL E D, 109(2), 2001, pp. 93-101
5. Gupta, M; Noel, GJ; Schaefer, M; Friedman, D; Bussel, J; Johann-Liang, R
   Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment
   JOURNAL OF CLINICAL IMMUNOLOGY
   
   M. Gupta et al., "Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment", J CLIN IMM, 21(3), 2001, pp. 193-199
6. Moldoveanu, AI; Shephard, RJ; Shek, PN
   The cytokine response to physical activity and training
   SPORTS MEDICINE
   
   A.I. Moldoveanu et al., "The cytokine response to physical activity and training", SPORT MED, 31(2), 2001, pp. 115-144
7. Bode, JG; Fischer, R; Haussinger, D; Graeve, L; Heinrich, PC; Schaper, F
   The inhibitory effect of IL-1 beta on IL-6-induced alpha(2)-macroglobulin expression is due to activation of NF-kappa B
   JOURNAL OF IMMUNOLOGY
   
   J.G. Bode et al., "The inhibitory effect of IL-1 beta on IL-6-induced alpha(2)-macroglobulin expression is due to activation of NF-kappa B", J IMMUNOL, 167(3), 2001, pp. 1469-1481
8. Meier-Ewert, HK; Ridker, PM; Rifai, N; Price, N; Dinges, DF; Mullington, JM
   Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects
   CLINICAL CHEMISTRY
   
   H.K. Meier-Ewert et al., "Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects", CLIN CHEM, 47(3), 2001, pp. 426-430
9. Tsunoda, S; Ishikawa, T; Watanabe, M; Kamada, H; Yamamoto, Y; Tsutsumi, Y; Hirano, T; Mayumi, T
   Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent
   BRITISH JOURNAL OF HAEMATOLOGY
   
   S. Tsunoda et al., "Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent", BR J HAEM, 112(1), 2001, pp. 181-188
10. Kaser, A; Brandacher, G; Steurer, W; Kaser, S; Offner, FA; Zoller, H; Theurl, I; Widder, W; Molnar, C; Ludwiczek, O; Atkins, MB; Mier, JW; Tilg, H
    Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
    BLOOD
    
    A. Kaser et al., "Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis", BLOOD, 98(9), 2001, pp. 2720-2725
11. Olencki, T; Finke, J; Tubbs, R; Elson, P; McLain, D; Herzog, P; Budd, GT; Gunn, H; Bukowski, RM
    Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects
    JOURNAL OF IMMUNOTHERAPY
    
    T. Olencki et al., "Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects", J IMMUNOTH, 23(5), 2000, pp. 549-556
12. Ebersole, JL; Cappelli, D
    Acute-phase reactants in infections and inflammatory diseases
    PERIODONTOLOGY 2000
    
    J.L. Ebersole e D. Cappelli, "Acute-phase reactants in infections and inflammatory diseases", PERIODONTOL, 23, 2000, pp. 19-49
13. Fennekohl, A; Lucas, M; Puschel, GP
    Induction by interleukin 6 of G(s)-coupled prostaglandin E-2 receptors in rat hepatocytes mediating a prostaglandin E-2-dependent inhibition of the hepatocyte's acute phase response
    HEPATOLOGY
    
    A. Fennekohl et al., "Induction by interleukin 6 of G(s)-coupled prostaglandin E-2 receptors in rat hepatocytes mediating a prostaglandin E-2-dependent inhibition of the hepatocyte's acute phase response", HEPATOLOGY, 31(5), 2000, pp. 1128-1134
14. Tsunoda, S; Kamada, H; Yamamoto, Y; Ishikawa, T; Matsui, J; Koizumi, K; Kaneda, Y; Tsutsumi, Y; Ohsugi, Y; Hirano, T; Mayumi, T
    Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice
    JOURNAL OF CONTROLLED RELEASE
    
    S. Tsunoda et al., "Molecular design of polyvinylpyrrolidone-conjugated interleukin-6 for enhancement of in vivo thrombopoietic activity in mice", J CONTR REL, 68(3), 2000, pp. 335-341
15. Ershler, WB; Keller, ET
    Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
    ANNUAL REVIEW OF MEDICINE
    
    W.B. Ershler e E.T. Keller, "Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty", ANN R MED, 51, 2000, pp. 245-270
16. Cartmell, T; Poole, S; Turnbull, AV; Rothwell, NJ; Luheshi, GN
    Circulating interleukin-6 mediates the febrile response to localised inflammation in rats
    JOURNAL OF PHYSIOLOGY-LONDON
    
    T. Cartmell et al., "Circulating interleukin-6 mediates the febrile response to localised inflammation in rats", J PHYSL LON, 526(3), 2000, pp. 653-661
17. Redwine, L; Hauger, RL; Gillin, JC; Irwin, M
    Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    L. Redwine et al., "Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans", J CLIN END, 85(10), 2000, pp. 3597-3603
18. Gonzalez-Ramon, N; Hoebe, K; Alava, MA; van Leengoed, L; Pineiro, M; Carmona, S; Iturralde, M; Lampreave, F; Pineiro, A
    Pig MAP/ITIH4 and haptoglobin are interleukin-6-dependent acute-phase plasma proteins in porcine primary cultured hepatocytes
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    N. Gonzalez-Ramon et al., "Pig MAP/ITIH4 and haptoglobin are interleukin-6-dependent acute-phase plasma proteins in porcine primary cultured hepatocytes", EUR J BIOCH, 267(6), 2000, pp. 1878-1885
19. Matthews, JM; Norton, RS; Hammacher, A; Simpson, RJ
    The single mutation Phe173 -> Ala induces a molten globule-like state in murine interleukin-6
    BIOCHEMISTRY
    
    J.M. Matthews et al., "The single mutation Phe173 -> Ala induces a molten globule-like state in murine interleukin-6", BIOCHEM, 39(8), 2000, pp. 1942-1950
20. O'Reilly, M; Newcomb, DE; Remick, D
    Endotoxin, sepsis, and the primrose path
    SHOCK
    
    M. O'Reilly et al., "Endotoxin, sepsis, and the primrose path", SHOCK, 12(6), 1999, pp. 411-420
21. Brown, PD; Diamant, M; Jensen, PO; Geisler, CH; Mortensen, BT; Nissen, NI
    S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma
    LEUKEMIA & LYMPHOMA
    
    P.D. Brown et al., "S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma", LEUK LYMPH, 34(3-4), 1999, pp. 325-333
22. Menzel, T; Bergmann, L
    Treatment strategies in metastatic renal cell carcinoma
    ONKOLOGIE
    
    T. Menzel e L. Bergmann, "Treatment strategies in metastatic renal cell carcinoma", ONKOLOGIE, 22(6), 1999, pp. 472-476
23. Antonen, J; Saha, H; Hulkkonen, J; Lumio, J; Pasternack, A; Hurme, M
    Increased in vitro production of interleukin 6 in response to trimethoprimamong persons with trimethoprim induced systemic adverse reactions
    JOURNAL OF RHEUMATOLOGY
    
    J. Antonen et al., "Increased in vitro production of interleukin 6 in response to trimethoprimamong persons with trimethoprim induced systemic adverse reactions", J RHEUMATOL, 26(12), 1999, pp. 2585-2590
24. Caen, JP; Han, ZC; Bellucci, S; Alemany, M
    Regulation of megakaryocytopoiesis
    HAEMOSTASIS
    
    J.P. Caen et al., "Regulation of megakaryocytopoiesis", HAEMOSTASIS, 29(1), 1999, pp. 27-40
25. Ramadori, G; Christ, B
    Cytokines and the hepatic acute-phase response
    SEMINARS IN LIVER DISEASE
    
    G. Ramadori e B. Christ, "Cytokines and the hepatic acute-phase response", SEM LIV DIS, 19(2), 1999, pp. 141-155
26. Zhang, GJ; Adachi, I
    Serum interleukin-6 levels correlate to tumor progression and prognosis inmetastatic breast carcinoma
    ANTICANCER RESEARCH
    
    G.J. Zhang e I. Adachi, "Serum interleukin-6 levels correlate to tumor progression and prognosis inmetastatic breast carcinoma", ANTICANC R, 19(2B), 1999, pp. 1427-1432
27. Guillonneau, F; Drechou, A; Pous, C; Chevalier, S; Lardeux, B; Cassio, D; Durand, G
    Hepatocyte differentiation of WIF-B cells includes a high capacity of interleukin-6-mediated induction of alpha(1)-acid glycoprotein and alpha(2)-macroglobulin
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    
    F. Guillonneau et al., "Hepatocyte differentiation of WIF-B cells includes a high capacity of interleukin-6-mediated induction of alpha(1)-acid glycoprotein and alpha(2)-macroglobulin", BBA-MOL CEL, 1448(3), 1999, pp. 403-408
28. Weisbach, V; Friedlein, H; Glaser, A; Zingsem, J; Zimmermann, R; Eckstein, R
    The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors
    TRANSFUSION
    
    V. Weisbach et al., "The influence of automated plateletpheresis on systemic levels of hematopoietic growth factors", TRANSFUSION, 39(8), 1999, pp. 889-894
29. Tsigos, C; Kyrou, L; Chala, E; Tsapogas, P; Stavridis, JC; Raptis, SA; Katsilambros, N
    Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    C. Tsigos et al., "Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity", METABOLISM, 48(10), 1999, pp. 1332-1335
30. Rieux, C; Lee, K; Lavaud, A; Bierling, P
    Transfusion of platelet concentrates.
    ANNALES DE MEDECINE INTERNE
    
    C. Rieux et al., "Transfusion of platelet concentrates.", ANN MED IN, 150(8), 1999, pp. 631-641
31. Reinisch, W; Gasche, C; Tillinger, W; Wyatt, J; Lichtenberger, C; Willheim, M; Dejaco, C; Waldhor, T; Bakos, S; Vogelsang, H; Gangl, A; Lochs, H
    Clinical relevance of serum interleukin-4 in Crohn's disease: Single pointmeasurements, therapy monitoring and prediction of clinical relapse
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    W. Reinisch et al., "Clinical relevance of serum interleukin-4 in Crohn's disease: Single pointmeasurements, therapy monitoring and prediction of clinical relapse", AM J GASTRO, 94(8), 1999, pp. 2156-2164
32. Gysler, J; Mazereeuw, M; Helk, B; Heitzmann, M; Jaehde, U; Schunack, W; Tjaden, UR; van der Greef, J
    Utility of isotachophoresis-capillary zone electrophoresis, mass spectrometry and high-performance size-exclusion chromatography for monitoring of interleukin-6 dimer formation
    JOURNAL OF CHROMATOGRAPHY A
    
    J. Gysler et al., "Utility of isotachophoresis-capillary zone electrophoresis, mass spectrometry and high-performance size-exclusion chromatography for monitoring of interleukin-6 dimer formation", J CHROMAT A, 841(1), 1999, pp. 63-73
33. PENTTILA IA; HARRIS RJ; STORM P; HAYNES D; WORSWICK DA; MARMION BP
    CYTOKINE DYSREGULATION IN THE POST-Q-FEVER FATIGUE SYNDROME
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    I.A. Penttila et al., "CYTOKINE DYSREGULATION IN THE POST-Q-FEVER FATIGUE SYNDROME", QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(8), 1998, pp. 549-560
34. BOSZE S; KAJTAR J; SZABO R; FALUS A; HUDECZ F
    SYNTHESIS, SOLUTION CONFORMATION AND INTERLEUKIN-6-RELATED ACTIVITIESOF INTERLEUKIN-6 PEPTIDES
    The journal of peptide research
    
    S. Bosze et al., "SYNTHESIS, SOLUTION CONFORMATION AND INTERLEUKIN-6-RELATED ACTIVITIESOF INTERLEUKIN-6 PEPTIDES", The journal of peptide research, 52(3), 1998, pp. 216-228
35. MIYAWAKI T; MAEDA S; KOYAMA Y; FUKUOKA R; SHIMADA M
    ELEVATION OF PLASMA INTERLEUKIN-6 LEVEL IS INVOLVED IN POSTOPERATIVE FEVER FOLLOWING MAJOR ORAL AND MAXILLOFACIAL SURGERY
    Oral surgery, oral medicine, oral pathology, oral radiology and endodontics
    
    T. Miyawaki et al., "ELEVATION OF PLASMA INTERLEUKIN-6 LEVEL IS INVOLVED IN POSTOPERATIVE FEVER FOLLOWING MAJOR ORAL AND MAXILLOFACIAL SURGERY", Oral surgery, oral medicine, oral pathology, oral radiology and endodontics, 85(2), 1998, pp. 146-152
36. RAMSEY G
    HEMATOPOIETIC GROWTH-FACTORS AND TRANSFUSION MEDICINE
    Transfusion medicine reviews
    
    G. Ramsey, "HEMATOPOIETIC GROWTH-FACTORS AND TRANSFUSION MEDICINE", Transfusion medicine reviews, 12(3), 1998, pp. 195-205
37. VOISIN L; BREUILLE D; RUOT B; RALLIERE C; RAMBOURDIN F; DALLE M; OBLED C
    CYTOKINE MODULATION BY PX DIFFERENTLY AFFECTS SPECIFIC ACUTE-PHASE PROTEINS DURING SEPSIS IN RATS
    American journal of physiology. Regulatory, integrative and comparative physiology
    
    L. Voisin et al., "CYTOKINE MODULATION BY PX DIFFERENTLY AFFECTS SPECIFIC ACUTE-PHASE PROTEINS DURING SEPSIS IN RATS", American journal of physiology. Regulatory, integrative and comparative physiology, 44(5), 1998, pp. 1412-1419
38. YOSHIZAKI K; NISHIMOTO N; MIHARA M; KISHIMOTO T
    THERAPY OF RHEUMATOID-ARTHRITIS BY BLOCKING IL-6 SIGNAL-TRANSDUCTION WITH A HUMANIZED ANTI-IL-6 RECEPTOR ANTIBODY
    Perspectives in mathematical logic
    
    K. Yoshizaki et al., "THERAPY OF RHEUMATOID-ARTHRITIS BY BLOCKING IL-6 SIGNAL-TRANSDUCTION WITH A HUMANIZED ANTI-IL-6 RECEPTOR ANTIBODY", Perspectives in mathematical logic, 20(1-2), 1998, pp. 247-259
39. SHINKURA H; IMAZEKI I; YAMAZAKI M; ODA Y; KOTOH M; MIHARA M
    IN-VIVO BLOCKING EFFECTS OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR ON INTERLEUKIN-6 FUNCTION IN PRIMATES
    Anticancer research
    
    H. Shinkura et al., "IN-VIVO BLOCKING EFFECTS OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR ON INTERLEUKIN-6 FUNCTION IN PRIMATES", Anticancer research, 18(2A), 1998, pp. 1217-1221
40. IMAZEKI I; SAITO H; HASEGAWA M; SHINKURA H; KISHIMOTO T; OHSUGI Y
    IL-6 FUNCTIONS IN CYNOMOLGUS MONKEYS BLOCKED BY A HUMANIZED ANTIBODY TO HUMAN IL-6 RECEPTOR
    International journal of immunopharmacology
    
    I. Imazeki et al., "IL-6 FUNCTIONS IN CYNOMOLGUS MONKEYS BLOCKED BY A HUMANIZED ANTIBODY TO HUMAN IL-6 RECEPTOR", International journal of immunopharmacology, 20(7), 1998, pp. 345-357
41. ROSENBAUM JT; KIEVIT P; HAN YB; PARK JM; PLANCK SR
    INTERLEUKIN-6 DOES NOT MEDIATE ENDOTOXIN-INDUCED UVEITIS IN MICE - STUDIES IN GENE DELETION ANIMALS
    Investigative ophthalmology & visual science
    
    J.T. Rosenbaum et al., "INTERLEUKIN-6 DOES NOT MEDIATE ENDOTOXIN-INDUCED UVEITIS IN MICE - STUDIES IN GENE DELETION ANIMALS", Investigative ophthalmology & visual science, 39(1), 1998, pp. 64-69
42. BROWN PD; JENSEN PO; DIAMANT M; MORTENSEN BT; HOVGAARD D; GIMSING P; NISSEN NI
    S-PHASE INDUCTION BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA
    Leukemia research
    
    P.D. Brown et al., "S-PHASE INDUCTION BY INTERLEUKIN-6 FOLLOWED BY CHEMOTHERAPY IN PATIENTS WITH REFRACTORY MULTIPLE-MYELOMA", Leukemia research, 22(11), 1998, pp. 983-989
43. WALTHER MM; JOHNSON B; CULLEY D; SHAH R; WEBER J; VENZON D; YANG JC; LINEHAN WH; ROSENBERG SA
    SERUM INTERLEUKIN-6 LEVELS IN METASTATIC RENAL-CELL CARCINOMA BEFORE TREATMENT WITH INTERLEUKIN-2 CORRELATES WITH PARANEOPLASTIC SYNDROMES BUT NOT PATIENT SURVIVAL
    The Journal of urology
    
    M.M. Walther et al., "SERUM INTERLEUKIN-6 LEVELS IN METASTATIC RENAL-CELL CARCINOMA BEFORE TREATMENT WITH INTERLEUKIN-2 CORRELATES WITH PARANEOPLASTIC SYNDROMES BUT NOT PATIENT SURVIVAL", The Journal of urology, 159(3), 1998, pp. 718-722
44. VANZAANEN HCT; LOKHORST HM; AARDEN LA; RENSINK HJAM; WARNAAR SO; VANDERLELIE J; VANOERS MHJ
    CHIMERIC ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES IN THE TREATMENT OFADVANCED MULTIPLE-MYELOMA - A PHASE-I DOSE-ESCALATING STUDY
    British Journal of Haematology
    
    H.C.T. Vanzaanen et al., "CHIMERIC ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES IN THE TREATMENT OFADVANCED MULTIPLE-MYELOMA - A PHASE-I DOSE-ESCALATING STUDY", British Journal of Haematology, 102(3), 1998, pp. 783-790
45. SOSMAN JA; ARONSON FR; SZNOL M; ATKINS MB; DUTCHER JP; WEISS GR; ISAACS RE; MARGOLIN KA; FISHER RI; ERNEST ML; MIER J; OLEKSOWICZ L; ECKHARDT JR; LEVITT D; DOROSHOW JH
    CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY
    Clinical cancer research
    
    J.A. Sosman et al., "CONCURRENT PHASE-I TRIALS OF INTRAVENOUS INTERLEUKIN-6 IN SOLID TUMORPATIENTS - REVERSIBLE DOSE-LIMITING NEUROLOGICAL TOXICITY", Clinical cancer research, 3(1), 1997, pp. 39-46
46. IMRIE KR; SHERIDAN B; COLWILL R; CRUMP M; STEWART AK; MCCRAE J; DANISH R; SUTTON D; ROMEYER F; KEATING A
    A PHASE-I STUDY OF INTERLEUKIN-6 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE
    Leukemia & lymphoma
    
    K.R. Imrie et al., "A PHASE-I STUDY OF INTERLEUKIN-6 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE", Leukemia & lymphoma, 25(5-6), 1997, pp. 555-563
47. SIMPSON RJ; HAMMACHER A; SMITH DK; MATTHEWS JM; WARD LD
    INTERLEUKIN-6 - STRUCTURE-FUNCTION-RELATIONSHIPS
    Protein science
    
    R.J. Simpson et al., "INTERLEUKIN-6 - STRUCTURE-FUNCTION-RELATIONSHIPS", Protein science, 6(5), 1997, pp. 929-955
48. YOUNG RI; RANSON M; CHANG J; LORD B; TESTA N; SCARFFE JH
    PHASE-II TRIAL OF RHIL-6 (INTERLEUKIN-6) PRIOR TO AND CONCURRENTLY WITH VAD (VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE) CHEMOTHERAPY FOR PATIENTS WITH MULTIPLE-MYELOMA
    European journal of cancer
    
    R.I. Young et al., "PHASE-II TRIAL OF RHIL-6 (INTERLEUKIN-6) PRIOR TO AND CONCURRENTLY WITH VAD (VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE) CHEMOTHERAPY FOR PATIENTS WITH MULTIPLE-MYELOMA", European journal of cancer, 33(2), 1997, pp. 307-311
49. BOUFFET E; PHILIP T; NEGRIER C; FFRENCH M; FRAPPAZ D; GENTILHOMME O; GIANELLABORRADORI A; BRUNATMENTIGNY M; BLAY JY
    PHASE-I STUDY OF INTERLEUKIN-6 IN CHILDREN WITH SOLID TUMORS IN RELAPSE
    European journal of cancer
    
    E. Bouffet et al., "PHASE-I STUDY OF INTERLEUKIN-6 IN CHILDREN WITH SOLID TUMORS IN RELAPSE", European journal of cancer, 33(10), 1997, pp. 1620-1626
50. VINCENTNAULLEAU S; THIBAULT D; NEWAY T; PILET C
    STIMULATORY EFFECTS OF POLAR GLYCOPEPTIDOLIPIDS OF MYCOBACTERIUM-CHELONAE ON MURINE HEMATOPOIETIC STEM-CELLS AND MEGAKARYOCYTE PROGENITORS
    Research in immunology
    
    S. Vincentnaulleau et al., "STIMULATORY EFFECTS OF POLAR GLYCOPEPTIDOLIPIDS OF MYCOBACTERIUM-CHELONAE ON MURINE HEMATOPOIETIC STEM-CELLS AND MEGAKARYOCYTE PROGENITORS", Research in immunology, 148(2), 1997, pp. 127-136
51. KEMPIN SJ
    HEMOSTATIC DEFECTS IN CANCER-PATIENTS
    Cancer investigation
    
    S.J. Kempin, "HEMOSTATIC DEFECTS IN CANCER-PATIENTS", Cancer investigation, 15(1), 1997, pp. 23-36
52. TSUTSUMI Y; TSUNODA SI; KAMADA H; KIHIRA T; KANEDA Y; OHSUGI Y; MAYUMI T
    PEGYLATION OF INTERLEUKIN-6 EFFECTIVELY INCREASES ITS THROMBOPOIETIC POTENCY
    Thrombosis and haemostasis
    
    Y. Tsutsumi et al., "PEGYLATION OF INTERLEUKIN-6 EFFECTIVELY INCREASES ITS THROMBOPOIETIC POTENCY", Thrombosis and haemostasis, 77(1), 1997, pp. 168-173
53. JONGENLAVRENCIC M; PEETERS HRM; WOGNUM A; VREUGDENHIL G; BREEDVELD FC; SWAAK AJG
    ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE
    Journal of rheumatology
    
    M. Jongenlavrencic et al., "ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE", Journal of rheumatology, 24(8), 1997, pp. 1504-1509
54. SHINKURA H; IMAZEKI I; FUKUSHIMA N; CHIBA N; TAKAHASHI F; AIKAWA H; KITAMURA H; FURUICHI T; HORIBA N; OHSUGI Y
    SAFETY AND KINETIC-PROPERTIES OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR IN HEALTHY NONHUMAN-PRIMATES
    Toxicology
    
    H. Shinkura et al., "SAFETY AND KINETIC-PROPERTIES OF A HUMANIZED ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR IN HEALTHY NONHUMAN-PRIMATES", Toxicology, 122(3), 1997, pp. 163-170
55. WEINHOLD B; BADER A; POLI V; RUTHER U
    INTERLEUKIN-6 IS NECESSARY, BUT NOT SUFFICIENT, FOR INDUCTION OF THE HUMAN C-REACTIVE PROTEIN GENE IN-VIVO
    Biochemical journal
    
    B. Weinhold et al., "INTERLEUKIN-6 IS NECESSARY, BUT NOT SUFFICIENT, FOR INDUCTION OF THE HUMAN C-REACTIVE PROTEIN GENE IN-VIVO", Biochemical journal, 325, 1997, pp. 617-621
56. NAMBA K; YAMAMURA E; NITANAI H; OTANI T; AZUMA I
    ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE, PROMOTES MEGAKARYOCYTOPOIESIS THROUGH STIMULATION OF CYTOKINE PRODUCTION IN NONHUMAN-PRIMATES WITH MYELOSUPPRESSION
    Vaccine
    
    K. Namba et al., "ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE, PROMOTES MEGAKARYOCYTOPOIESIS THROUGH STIMULATION OF CYTOKINE PRODUCTION IN NONHUMAN-PRIMATES WITH MYELOSUPPRESSION", Vaccine, 15(4), 1997, pp. 405-413
57. YOKOE T; IINO Y; TAKEI H; HORIGUCHI J; KOIBUCHI Y; MAEMURA M; OHWADA S; MORISHITA Y
    CHANGES OF CYTOKINES AND THYROID-FUNCTION IN PATIENTS WITH RECURRENT BREAST-CANCER
    Anticancer research
    
    T. Yokoe et al., "CHANGES OF CYTOKINES AND THYROID-FUNCTION IN PATIENTS WITH RECURRENT BREAST-CANCER", Anticancer research, 17(1B), 1997, pp. 695-699
58. BARTON BE
    IL-6 - INSIGHTS INTO NOVEL BIOLOGICAL-ACTIVITIES
    Clinical immunology and immunopathology
    
    B.E. Barton, "IL-6 - INSIGHTS INTO NOVEL BIOLOGICAL-ACTIVITIES", Clinical immunology and immunopathology, 85(1), 1997, pp. 16-20
59. KAMMULLER M; RYFFEL B
    EXTRAPOLATION OF EXPERIMENTAL SAFETY DATA TO HUMANS - THE INTERLEUKIN-6 CASE
    Clinical immunology and immunopathology
    
    M. Kammuller e B. Ryffel, "EXTRAPOLATION OF EXPERIMENTAL SAFETY DATA TO HUMANS - THE INTERLEUKIN-6 CASE", Clinical immunology and immunopathology, 83(1), 1997, pp. 15-17
60. WOJCIECHOWSKALACKA A; ADAMIAK E; STRYCZYNSKA G; LACKI JK
    PROGNOSTIC VALUE OF SERIAL SERUM INTERLEUKIN-6 LEVEL ESTIMATION IN PATIENTS WITH LUNG-CANCER - A PRELIMINARY-REPORT
    The Yale journal of biology & medicine
    
    A. Wojciechowskalacka et al., "PROGNOSTIC VALUE OF SERIAL SERUM INTERLEUKIN-6 LEVEL ESTIMATION IN PATIENTS WITH LUNG-CANCER - A PRELIMINARY-REPORT", The Yale journal of biology & medicine, 70(2), 1997, pp. 139-148
61. IGARASHI R; TSUTSUMI Y; FUJII H; TSUNODA S; OCHIAI A; TAKENAGA M; MORIZAWA Y; MAYUMI T; MIZUSHIMA Y
    LECITHINIZATION OF IL-6 ENHANCES ITS THROMBOPOIETIC ACTIVITY IN MICE
    Journal of Pharmacy and Pharmacology
    
    R. Igarashi et al., "LECITHINIZATION OF IL-6 ENHANCES ITS THROMBOPOIETIC ACTIVITY IN MICE", Journal of Pharmacy and Pharmacology, 49(1), 1997, pp. 113-118
62. KOISTINEN P; SAILY M; POROMAA N; SAVOLAINEN ER
    COMPLEX EFFECTS OF INTERLEUKIN-6 ON CLONOGENIC BLAST CELL-GROWTH IN ACUTE MYELOBLASTIC-LEUKEMIA
    Acta haematologica
    
    P. Koistinen et al., "COMPLEX EFFECTS OF INTERLEUKIN-6 ON CLONOGENIC BLAST CELL-GROWTH IN ACUTE MYELOBLASTIC-LEUKEMIA", Acta haematologica, 98(1), 1997, pp. 14-21
63. RICHARDS CD; LANGDON C; PENNICA D; GAULDIE J
    MURINE CARDIOTROPHIN-1 STIMULATES THE ACUTE-PHASE RESPONSE IN RAT HEPATOCYTES AND H35 HEPATOMA-CELLS
    Journal of interferon & cytokine research
    
    C.D. Richards et al., "MURINE CARDIOTROPHIN-1 STIMULATES THE ACUTE-PHASE RESPONSE IN RAT HEPATOCYTES AND H35 HEPATOMA-CELLS", Journal of interferon & cytokine research, 16(1), 1996, pp. 69-75
64. CLARKE D; JOHNSON PWM; BANKS RE; STORR M; KINSEY SE; JOHNSON R; MORGAN G; GORDON MY; ILLINGWORTH JM; PERREN TJ; SELBY PJ
    EFFECTS OF INTERLEUKIN-6 ADMINISTRATION ON PLATELETS AND HEMATOPOIETIC PROGENITOR CELLS IN PERIPHERAL-BLOOD
    Cytokine
    
    D. Clarke et al., "EFFECTS OF INTERLEUKIN-6 ADMINISTRATION ON PLATELETS AND HEMATOPOIETIC PROGENITOR CELLS IN PERIPHERAL-BLOOD", Cytokine, 8(9), 1996, pp. 717-723
65. LATERVEER L; ZIJLMANS JMJM; LIEHL E; WILLEMZE R; FIBBE WE
    ACCELERATED PLATELET RECONSTITUTION FOLLOWING TRANSPLANTATION OF BONE-MARROW CELLS DERIVED FROM IL-6-TREATED DONOR MICE
    Annals of hematology
    
    L. Laterveer et al., "ACCELERATED PLATELET RECONSTITUTION FOLLOWING TRANSPLANTATION OF BONE-MARROW CELLS DERIVED FROM IL-6-TREATED DONOR MICE", Annals of hematology, 73(5), 1996, pp. 239-245
66. BAATOUT S
    INTERLEUKIN-6 AND MEGAKARYOCYTOPOIESIS - AN UPDATE
    Annals of hematology
    
    S. Baatout, "INTERLEUKIN-6 AND MEGAKARYOCYTOPOIESIS - AN UPDATE", Annals of hematology, 73(4), 1996, pp. 157-162
67. VELDHUIS GJ; VANDERLEEST AHD; DEWOLF JTM; DEVRIES EGE; VELLENGA E
    A CASE OF LOCALIZED CASTLEMANS-DISEASE WITH SYSTEMIC INVOLVEMENT - TREATMENT AND PATHOGENETIC ASPECTS
    Annals of hematology
    
    G.J. Veldhuis et al., "A CASE OF LOCALIZED CASTLEMANS-DISEASE WITH SYSTEMIC INVOLVEMENT - TREATMENT AND PATHOGENETIC ASPECTS", Annals of hematology, 73(1), 1996, pp. 47-50
68. SELIG C; KREJA L; NOTHDURFT W
    INVESTIGATION OF MEGAKARYOPOIESIS IN MYELOSUPPRESSED BONE-MARROW USING IMMUNOGOLD-SILVER STAINING (IGSS)
    European journal of haematology
    
    C. Selig et al., "INVESTIGATION OF MEGAKARYOPOIESIS IN MYELOSUPPRESSED BONE-MARROW USING IMMUNOGOLD-SILVER STAINING (IGSS)", European journal of haematology, 56(5), 1996, pp. 293-300
69. ROZEMULLER H; ROMBOUTS WJC; TOUW IP; FITZGERALD DJP; KREITMAN RJ; PASTAN I; HAGENBEEK A; MARTENS ACM
    TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA WITH INTERLEUKIN-6 PSEUDOMONASEXOTOXIN FUSION PROTEIN IN A RAT LEUKEMIA MODEL
    Leukemia
    
    H. Rozemuller et al., "TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA WITH INTERLEUKIN-6 PSEUDOMONASEXOTOXIN FUSION PROTEIN IN A RAT LEUKEMIA MODEL", Leukemia, 10(11), 1996, pp. 1796-1803
70. GROSSMANN A; LENOX J; REN HP; HUMES JM; FORSTROM JW; KAUSHANSKY K; SPRUGEL KH
    THROMBOPOIETIN ACCELERATES PLATELET, RED-BLOOD-CELL, AND NEUTROPHIL RECOVERY IN MYELOSUPPRESSED MICE
    Experimental hematology
    
    A. Grossmann et al., "THROMBOPOIETIN ACCELERATES PLATELET, RED-BLOOD-CELL, AND NEUTROPHIL RECOVERY IN MYELOSUPPRESSED MICE", Experimental hematology, 24(10), 1996, pp. 1238-1246
71. STEFFEN M; DURKEN M; PICHLMEIER U; VONDEMBUSCHE C; STOCKSCHLADER M; KRUGER W; BUDDESTEFFEN C; ZANDER A
    SERUM INTERLEUKIN-6 LEVELS DURING BONE-MARROW TRANSPLANTATION - IMPACT ON TRANSPLANT-RELATED TOXICITY AND ENGRAFTMENT
    Bone marrow transplantation
    
    M. Steffen et al., "SERUM INTERLEUKIN-6 LEVELS DURING BONE-MARROW TRANSPLANTATION - IMPACT ON TRANSPLANT-RELATED TOXICITY AND ENGRAFTMENT", Bone marrow transplantation, 18(2), 1996, pp. 301-307
72. NAMBA K; NITANAI H; OTANI T; AZUMA I
    ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE, ACCELERATES PERIPHERAL PLATELET RECOVERY IN NONHUMAN PRIMATE CHEMOTHERAPY MODEL
    Vaccine
    
    K. Namba et al., "ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE, ACCELERATES PERIPHERAL PLATELET RECOVERY IN NONHUMAN PRIMATE CHEMOTHERAPY MODEL", Vaccine, 14(14), 1996, pp. 1322-1326
73. BARTON BE
    THE BIOLOGICAL EFFECTS OF INTERLEUKIN-6
    Medicinal research reviews
    
    B.E. Barton, "THE BIOLOGICAL EFFECTS OF INTERLEUKIN-6", Medicinal research reviews, 16(1), 1996, pp. 87-109
74. OHIRA T; NISHIO K; OHE Y; ARIOKA H; NISHIO M; FUNAYAMA Y; OGASAWARA H; FUKUDA M; YAZAWA K; KATO H; SAIJO N
    IMPROVEMENT BY EICOSANOIDS IN CANCER CACHEXIA INDUCED BY LLC-IL6 TRANSPLANTATION
    Journal of cancer research and clinical oncology
    
    T. Ohira et al., "IMPROVEMENT BY EICOSANOIDS IN CANCER CACHEXIA INDUCED BY LLC-IL6 TRANSPLANTATION", Journal of cancer research and clinical oncology, 122(12), 1996, pp. 711-715
75. JONGENLAVRENCIC M; PEETERS HRM; ROZEMULLER H; ROMBOUTS WJC; MARTENS ACM; VREUGDENHIL G; PILLAY M; COX PH; BIJSER M; BRUTEL G; BREEDVELD FC; SWAAK AJG
    IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS
    Clinical and experimental immunology
    
    M. Jongenlavrencic et al., "IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS", Clinical and experimental immunology, 103(2), 1996, pp. 328-334
76. GROSSMANN A; LENOX J; DEISHER TA; REN HP; HUMES JM; KAUSHANSKY K; SPRUGEL KH
    SYNERGISTIC EFFECTS OF THROMBOPOIETIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR ON NEUTROPHIL RECOVERY IN MYELOSUPPRESSED MICE
    Blood
    
    A. Grossmann et al., "SYNERGISTIC EFFECTS OF THROMBOPOIETIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR ON NEUTROPHIL RECOVERY IN MYELOSUPPRESSED MICE", Blood, 88(9), 1996, pp. 3363-3370
77. NAKAGAWATOSA N; MORIMATSU M; KAWASAKI M; NAKATSUJI H; SYUTO B; SAITO M
    STIMULATION OF HAPTOGLOBIN SYNTHESIS BY INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR, BUT NOT BY INTERLEUKIN-1, IN BOVINE PRIMARY CULTURED-HEPATOCYTES
    Journal of veterinary medical science
    
    N. Nakagawatosa et al., "STIMULATION OF HAPTOGLOBIN SYNTHESIS BY INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR, BUT NOT BY INTERLEUKIN-1, IN BOVINE PRIMARY CULTURED-HEPATOCYTES", Journal of veterinary medical science, 57(2), 1995, pp. 219-223
78. KAMMULLER ME
    RECOMBINANT HUMAN INTERLEUKIN-6 - SAFETY ISSUES OF A PLEIOTROPIC GROWTH-FACTOR
    Toxicology
    
    M.E. Kammuller, "RECOMBINANT HUMAN INTERLEUKIN-6 - SAFETY ISSUES OF A PLEIOTROPIC GROWTH-FACTOR", Toxicology, 105(1), 1995, pp. 91-107
79. MYERS LA; BOYCE JT; ROBISON RL
    THE TOLERABILITY AND PHARMACOLOGY OF INTERLEUKIN-6 ADMINISTERED IN COMBINATION WITH GM-CSF OR G-CSF IN THE RHESUS-MONKEY
    Toxicology
    
    L.A. Myers et al., "THE TOLERABILITY AND PHARMACOLOGY OF INTERLEUKIN-6 ADMINISTERED IN COMBINATION WITH GM-CSF OR G-CSF IN THE RHESUS-MONKEY", Toxicology, 101(3), 1995, pp. 157-166
80. BARRAUD B; BALAVOINE S; FELDMANN G; LARDEUX B
    EFFECTS OF NICOTINAMIDE ON HEPATOCYTE VIABILITY AND SECRETION OF ALBUMIN AND ALPHA(1)-ACID GLYCOPROTEIN BY ADULT-RAT HEPATOCYTES IN PRIMOCULTURE - COMPARISON WITH DEXAMETHASONE AND RECOMBINANT HUMAN INTERLEUKIN-6
    Biology of the cell
    
    B. Barraud et al., "EFFECTS OF NICOTINAMIDE ON HEPATOCYTE VIABILITY AND SECRETION OF ALBUMIN AND ALPHA(1)-ACID GLYCOPROTEIN BY ADULT-RAT HEPATOCYTES IN PRIMOCULTURE - COMPARISON WITH DEXAMETHASONE AND RECOMBINANT HUMAN INTERLEUKIN-6", Biology of the cell, 83(2-3), 1995, pp. 127-133
81. TSUTSUMI Y; KIHIRA T; TSUNODA S; OKADA N; KANEDA Y; OHSUGI Y; MIYAKE M; NAKAGAWA S; MAYUMI T
    POLYETHYLENE-GLYCOL MODIFICATION OF INTERLEUKIN-6 ENHANCES ITS THROMBOPOIETIC ACTIVITY
    Journal of controlled release
    
    Y. Tsutsumi et al., "POLYETHYLENE-GLYCOL MODIFICATION OF INTERLEUKIN-6 ENHANCES ITS THROMBOPOIETIC ACTIVITY", Journal of controlled release, 33(3), 1995, pp. 447-451
82. ENCINAS MMP; LOPEZ JLB; CRESPO SP; ACHIRICA IL
    C-REACTIVE PROTEIN IN THE DIFFERENTIAL-DI AGNOSIS OF PRIMARY THROMBOCYTOSIS
    Medicina Clinica
    
    M.M.P. Encinas et al., "C-REACTIVE PROTEIN IN THE DIFFERENTIAL-DI AGNOSIS OF PRIMARY THROMBOCYTOSIS", Medicina Clinica, 104(12), 1995, pp. 441-443
83. KONISHI H; OCHIYA T; SAKAMOTO H; TSUKAMOTO M; SAITO I; MUTO T; SUGIMURA T; TERADA M
    EFFECTIVE PREVENTION OF THROMBOCYTOPENIA IN MICE USING ADENOVIRUS-MEDIATED TRANSFER OF HST-1 (FGF-4) GENE
    The Journal of clinical investigation
    
    H. Konishi et al., "EFFECTIVE PREVENTION OF THROMBOCYTOPENIA IN MICE USING ADENOVIRUS-MEDIATED TRANSFER OF HST-1 (FGF-4) GENE", The Journal of clinical investigation, 96(2), 1995, pp. 1125-1130
84. ATKINS MB; KAPPLER K; MIER JW; ISAACS RE; BERKMAN EM
    INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM
    Blood
    
    M.B. Atkins et al., "INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM", Blood, 86(4), 1995, pp. 1288-1291
85. BATAILLE R; BARLOGIE B; LU ZY; ROSSI JF; LAVABREBERTRAND T; BECK T; WIJDENES J; BROCHIER J; KLEIN B
    BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA
    Blood
    
    R. Bataille et al., "BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA", Blood, 86(2), 1995, pp. 685-691
86. DHONDT V; HUMBLET Y; GUILLAUME T; BAATOUT S; CHATELAIN C; BERLIERE M; LONGUEVILLE J; FEYENS AM; DEGREVE J; VANOOSTEROM A; VONGRAFFENRIED B; DONNEZ J; SYMANN M
    THROMBOPOIETIC EFFECTS AND TOXICITY OF INTERLEUKIN-6 IN PATIENTS WITHOVARIAN-CANCER BEFORE AND AFTER CHEMOTHERAPY - A MULTICENTRIC PLACEBO-CONTROLLED, RANDOMIZED PHASE IB STUDY
    Blood
    
    V. Dhondt et al., "THROMBOPOIETIC EFFECTS AND TOXICITY OF INTERLEUKIN-6 IN PATIENTS WITHOVARIAN-CANCER BEFORE AND AFTER CHEMOTHERAPY - A MULTICENTRIC PLACEBO-CONTROLLED, RANDOMIZED PHASE IB STUDY", Blood, 85(9), 1995, pp. 2347-2353
87. LITTMAN BH; DRURY CE; ZIMMERER RO; STACK CB; LAW CG
    RHEUMATOID-ARTHRITIS TREATED WITH TENIDAP AND PIROXICAM - CLINICAL ASSOCIATIONS WITH CYTOKINE MODULATION BY TENIDAP
    Arthritis and rheumatism
    
    B.H. Littman et al., "RHEUMATOID-ARTHRITIS TREATED WITH TENIDAP AND PIROXICAM - CLINICAL ASSOCIATIONS WITH CYTOKINE MODULATION BY TENIDAP", Arthritis and rheumatism, 38(1), 1995, pp. 29-37
88. OLENCKI T; FINKE J; BUKOWSKI RM
    INTERLEUKIN-6 - POTENTIAL CLINICAL-APPLICATIONS IN CANCER-THERAPY
    CLINICAL IMMUNOTHERAPEUTICS
    
    T. Olencki et al., "INTERLEUKIN-6 - POTENTIAL CLINICAL-APPLICATIONS IN CANCER-THERAPY", CLINICAL IMMUNOTHERAPEUTICS, 2(4), 1994, pp. 278-294
89. BERNAD A; KOPF M; KULBACKI R; WEICH N; KOEHLER G; GUTIERREZRAMOS JC
    INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM
    Immunity
    
    A. Bernad et al., "INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM", Immunity, 1(9), 1994, pp. 725-731
90. WEBER J; GUNN H; YANG J; PARKINSON D; TOPALIAN S; SCHWARTZENTRUBER D; ETTINGHAUSEN S; LEVITT D; ROSENBERG SA
    A PHASE-I TRIAL OF INTRAVENOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED CANCER
    Journal of immunotherapy with emphasis on tumor immunology
    
    J. Weber et al., "A PHASE-I TRIAL OF INTRAVENOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED CANCER", Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 292-302
91. BURSTEIN SA
    EFFECTS OF INTERLEUKIN-6 ON MEGAKARYOCYTES AND ON CANINE PLATELET-FUNCTION
    Stem cells
    
    S.A. Burstein, "EFFECTS OF INTERLEUKIN-6 ON MEGAKARYOCYTES AND ON CANINE PLATELET-FUNCTION", Stem cells, 12(4), 1994, pp. 386-393
92. FOX LE; KING RR; SHI F; KURZMAN ID; MACEWEN EG; KUBILIS PS
    INDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 ACTIVITY BY LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE-PHOSPHATIDYLETHANOLAMINE (L-MTP-PE) IN NORMAL CATS
    Cancer biotherapy
    
    L.E. Fox et al., "INDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 ACTIVITY BY LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE-PHOSPHATIDYLETHANOLAMINE (L-MTP-PE) IN NORMAL CATS", Cancer biotherapy, 9(4), 1994, pp. 329-340
93. HONGBROWN LQ; BROWN CR
    CYTOKINE AND INSULIN REGULATION OF ALPHA-2-MACROGLOBULIN, ANGIOTENSINOGEN, AND HSP-70 IN PRIMARY CULTURED ASTROCYTES
    Glia
    
    L.Q. Hongbrown e C.R. Brown, "CYTOKINE AND INSULIN REGULATION OF ALPHA-2-MACROGLOBULIN, ANGIOTENSINOGEN, AND HSP-70 IN PRIMARY CULTURED ASTROCYTES", Glia, 12(3), 1994, pp. 211-218
94. MATSUDA Y; KAWATA S; NAGASE T; MAEDA Y; YAMASAKI E; KISO S; ISHIGURO H; MATSUZAWA Y
    INTERLEUKIN-6 IN TRANSCATHETER ARTERIAL EMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR-CARCINOMA - EFFECTS OF SERINE-PROTEASE INHIBITOR
    Cancer
    
    Y. Matsuda et al., "INTERLEUKIN-6 IN TRANSCATHETER ARTERIAL EMBOLIZATION FOR PATIENTS WITH HEPATOCELLULAR-CARCINOMA - EFFECTS OF SERINE-PROTEASE INHIBITOR", Cancer, 73(1), 1994, pp. 53-57
95. NAMBA K; OTANI T; OSADA Y
    ENHANCEMENT OF PLATELET RECOVERY IN X-IRRADIATED GUINEA-PIGS BY ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE
    Blood
    
    K. Namba et al., "ENHANCEMENT OF PLATELET RECOVERY IN X-IRRADIATED GUINEA-PIGS BY ROMURTIDE, A SYNTHETIC MURAMYL DIPEPTIDE DERIVATIVE", Blood, 83(9), 1994, pp. 2480-2488
96. RYFFEL B; CAR BD; WOERLY G; WEBER M; DIPADOVA F; KAMMULLER M; KLUG S; NEUBERT R; NEUBERT D
    LONG-TERM INTERLEUKIN-6 ADMINISTRATION STIMULATES SUSTAINED THROMBOPOIESIS AND ACUTE-PHASE PROTEIN-SYNTHESIS IN A SMALL PRIMATE - THE MARMOSET
    Blood
    
    B. Ryffel et al., "LONG-TERM INTERLEUKIN-6 ADMINISTRATION STIMULATES SUSTAINED THROMBOPOIESIS AND ACUTE-PHASE PROTEIN-SYNTHESIS IN A SMALL PRIMATE - THE MARMOSET", Blood, 83(8), 1994, pp. 2093-2102
97. PENG JP; FRIESE P; GEORGE JN; DALE GL; BURSTEIN SA
    ALTERATION OF PLATELET-FUNCTION IN DOGS MEDIATED BY INTERLEUKIN-6
    Blood
    
    J.P. Peng et al., "ALTERATION OF PLATELET-FUNCTION IN DOGS MEDIATED BY INTERLEUKIN-6", Blood, 83(2), 1994, pp. 398-403
98. GUNTHER M; HAUBECK HD; VANDELEUR E; BLASER J; BENDER S; GUTGEMANN I; FISCHER DC; TSCHESCHE H; GREILING H; HEINRICH PC; GRAEVE L
    TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES
    Arthritis and rheumatism
    
    M. Gunther et al., "TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES", Arthritis and rheumatism, 37(3), 1994, pp. 395-405
99. TRANTHI TA; WEINHOLD L; WEINSTOCK C; HOFFMANN R; SCHULZESPECKING A; NORTHOFF H; DECKER K
    PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1 AND INTERLEUKIN-6 IN THE PERFUSED-RAT-LIVER
    European cytokine network
    
    T.A. Tranthi et al., "PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1 AND INTERLEUKIN-6 IN THE PERFUSED-RAT-LIVER", European cytokine network, 4(5), 1993, pp. 363-370
100. CAEN JP; HAN ZC
     CONTROL OF MEGAKARYOCYTE DEVELOPMENT - FROM BASIC DATA TO CLINICAL-RESULTS
     Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie
     
     J.P. Caen e Z.C. Han, "CONTROL OF MEGAKARYOCYTE DEVELOPMENT - FROM BASIC DATA TO CLINICAL-RESULTS", Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 316(9), 1993, pp. 925-930